Page last updated: 2024-08-25

zoledronic acid and Hypogonadism

zoledronic acid has been researched along with Hypogonadism in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Irwig, MS	1
Aubry-Rozier, B; Lamy, O; Lucini, M; Stoll, D	1
Antunez, O; Boonen, S; Brixen, K; Bucci-Rechtweg, C; Claessens, F; Dimai, HP; Eriksen, E; Hruska, J; Incera, E; Kaufman, JM; Langdahl, B; Lippuner, K; Lipschitz, S; Orwoll, E; Papanastasiou, P; Reginster, JY; Rizzoli, R; Russo, L; Su, G; Vanderschueren, D; Witvrouw, R; Zanchetta, J	1
Delmas, PD; Vignot, E	1

Reviews

1 review(s) available for zoledronic acid and Hypogonadism

Article	Year
Male hypogonadism and skeletal health. Current opinion in endocrinology, diabetes, and obesity, 2013, Volume: 20, Issue:6 Topics: Androgen Antagonists; Antibodies, Monoclonal, Humanized; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Denosumab; Diphosphonates; Humans; Hypogonadism; Imidazoles; Immunologic Factors; Klinefelter Syndrome; Male; Men's Health; Osteoporosis; Prostatic Neoplasms, Castration-Resistant; Randomized Controlled Trials as Topic; Testosterone; Zoledronic Acid	2013

Article

Year

Male hypogonadism and skeletal health.

Current opinion in endocrinology, diabetes, and obesity, 2013, Volume: 20, Issue:6

Topics: Androgen Antagonists; Antibodies, Monoclonal, Humanized; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Denosumab; Diphosphonates; Humans; Hypogonadism; Imidazoles; Immunologic Factors; Klinefelter Syndrome; Male; Men's Health; Osteoporosis; Prostatic Neoplasms, Castration-Resistant; Randomized Controlled Trials as Topic; Testosterone; Zoledronic Acid

2013

Trials

1 trial(s) available for zoledronic acid and Hypogonadism

Article	Year
Fracture risk and zoledronic acid therapy in men with osteoporosis. The New England journal of medicine, 2012, 11-01, Volume: 367, Issue:18 Topics: Aged; Aged, 80 and over; Analysis of Variance; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Humans; Hypogonadism; Imidazoles; Logistic Models; Male; Middle Aged; Osteoporosis; Risk; Spinal Fractures; Testosterone; Zoledronic Acid	2012

Article

Year

Fracture risk and zoledronic acid therapy in men with osteoporosis.

The New England journal of medicine, 2012, 11-01, Volume: 367, Issue:18

Topics: Aged; Aged, 80 and over; Analysis of Variance; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Humans; Hypogonadism; Imidazoles; Logistic Models; Male; Middle Aged; Osteoporosis; Risk; Spinal Fractures; Testosterone; Zoledronic Acid

2012

Other Studies

2 other study(ies) available for zoledronic acid and Hypogonadism

Article	Year
[Should we treat thalassemia-induced osteoporosis: two case reports]. Praxis, 2012, Oct-03, Volume: 101, Issue:20 Topics: Absorptiometry, Photon; Adult; Antibodies, Monoclonal, Humanized; beta-Thalassemia; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Humans; Hypogonadism; Imidazoles; Infusions, Intravenous; Male; Osteoporosis; Zoledronic Acid	2012
[Advances in the field of osteoporosis]. La Revue du praticien, 2007, Oct-15, Volume: 57, Issue:15 Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Glucocorticoids; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Teriparatide; Thiophenes; Zoledronic Acid	2007